Osaic Holdings
DMAC icon

Osaic Holdings’s DiaMedica Therapeutics DMAC Stock Holding History

Osaic Holdings’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$125 Hold
25
– – ﹤0.01% 7607
2025
Q4 		$2.38K Buy
+25
New +$187 ﹤0.01% 7037

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Osaic Holdings's DMAC Position: Q1 2026 in Review

Osaic Holdings increased its DiaMedica Therapeutics (DMAC) stake by 29% in Q1 2026, buying an estimated $576K and bringing the position to 319,675 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2007.

Osaic Holdings first reported a position in DMAC in Q2 2023 and has held it in 12 quarters since. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • Osaic Holdings held 319,675 shares of DiaMedica Therapeutics worth $2.16M as of Q1 2026.
  • Osaic Holdings bought 72,703 DiaMedica Therapeutics shares in Q1 2026, an estimated $576K.
  • DiaMedica Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #2007 holding.
  • Osaic Holdings first reported a position in DiaMedica Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.